Marc Clausse, newly appointed CCO, added: “AGAMREE represents a meaningful advancement for patients with DMD, and Santhera is well positioned for its next phase of growth. I look forward to working ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results